Stock Incentive Plans (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Share-based Compensation Expense Recognized in the Period

The following table presents the share-based compensation expense recognized within the following line items in the Consolidated Statement of Operations and Comprehensive Income (Loss) and Consolidated Balance Sheet in the periods presented:

	Year Ended December 31,
	2024		2023		2022
Restricted stock units	$	107,699	$	99,648	$	76,094
Stock options	23,732		26,323		28,816
Performance restricted stock units	4,041		—		—
Employee Stock Purchase Plan	1,090		1,554		2,619
Share-based compensation recorded within Compensation and benefits	136,562		127,525		107,529
Executive chairman long-term performance award	(144,617)		53,214		53,214
Property and equipment (capitalized internal-use software)	7,059		4,492		—
Total share-based compensation expense	$	(996)	$	185,231	$	160,743

Schedule of RSU and Performance-based RSUs Activity Under the Plans

A summary of the Company's RSUs and PSUs activity under the Plans was as follows:

	Number of Units	Weighted-average grant date fair value per share
Balance as of December 31, 2022	34,147	$	9.74
Granted	31,061	4.62
Vested	(14,129)	8.47
Canceled and forfeited	(12,901)	7.98
Balance as of December 31, 2023	38,178	$	6.64
Granted	22,442	5.63
Vested	(18,274)	6.66
Canceled and forfeited	(8,540)	6.63
Balance as of December 31, 2024	33,806	$	5.96

A summary of the Company's stock option activity under the Plans is as follows:

	Number of Options	Weighted-Average Exercise Price per Share		Weighted-Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value(1)
Balance as of January 1, 2022	44,185	$	13.31	8.46	$	279,242
Granted	4,183	10.16
Exercised	(7,786)	1.20
Canceled and forfeited	(4,426)	6.60
Balance as of December 31, 2022	36,156	$	16.37	7.67	$	29,101
Granted	6,080	5.35
Exercised	(3,353)	1.58
Canceled and forfeited	(2,213)	13.24
Balance as of December 31, 2023	36,670	$	16.09	7.45	$	24,481
Granted	—	0.00
Exercised	(185)	1.10
Canceled and forfeited	(21,523)	21.01
Balance as of December 31, 2024	14,962	$	9.19	5.82	$	5,819
Exercisable as of December 31, 2024(2)	12,079	$	9.60	5.33	$	5,819
Vested as of December 31, 2024	11,666	$	9.53	5.28	$	5,819

(1) Intrinsic value is calculated based on the difference between the exercise price of in-the-money-stock options and the fair value of the common stock as of the respective balance sheet dates.

(2) The 2011 Plan allows for early exercise of stock options. Accordingly, options granted under this plan are included as exercisable stock options regardless of vesting status.

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair values of stock options granted were estimated using the Black-Scholes option pricing model and the following weighted-average assumptions:

	Year Ended December 31,
	2023	2022
Dividend yield	0.0%	0.0%
Expected volatility	70.78%	61.52%
Expected term (in years)	6.04	6.08
Risk-free interest rate	3.78%	2.32%

The Company did not grant any stock options during the year ended December 31, 2024.